Page 205 - Read Online
P. 205
Page 24 Asao et al. Extracell Vesicles Circ Nucleic Acids 2023;4:461-85 https://dx.doi.org/10.20517/evcna.2023.37
Mater 2023;22:656-65. DOI
139. Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling
compared to intracellular and cell-free blood. J Extracell Vesicles 2014;3:23743. DOI PubMed PMC
140. Zhou E, Li Y, Wu F, et al. Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy.
EBioMedicine 2021;67:103365. DOI PubMed PMC
141. Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature
2015;523:177-82. DOI PubMed PMC
142. McKiernan J, Donovan MJ, O'Neill V, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at
initial biopsy. JAMA Oncol 2016;2:882-9. DOI
143. Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva.
Blood 2011;117:3172-80. DOI PubMed
144. Lässer C, Alikhani VS, Ekström K, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J
Transl Med 2011;9:9. DOI PubMed PMC
145. Herreros-Villanueva M, Bujanda L. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med
2016;4:64. DOI PubMed PMC
146. Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J
Extracell Vesicles 2015;4:27066. DOI PubMed PMC
147. Øverbye A, Skotland T, Koehler CJ, et al. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget
2015;6:30357-76. DOI PubMed PMC
148. Zhang C, Wang XY, Zhang P, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by
reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death Dis 2022;13:57. DOI PubMed PMC
149. Sun H, Wang C, Hu B, et al. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis
by activating STAT3. Signal Transduct Target Ther 2021;6:187. DOI PubMed PMC
150. Plebanek MP, Angeloni NL, Vinokour E, et al. Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes
at the metastatic niche. Nat Commun 2017;8:1319. DOI PubMed PMC
151. Balaj L, Lessard R, Dai L, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat
Commun 2011;2:180. DOI PubMed PMC
152. Kahlert C, Melo SA, Protopopov A, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated
KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014;289:3869-75. DOI PubMed
PMC
153. Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res
2014;24:766-9. DOI PubMed PMC
154. Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J. Oncogenic ras-driven cancer cell vesiculation leads to
emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 2014;451:295-301. DOI
PubMed
155. Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology.
Nat Rev Genet 2019;20:71-88. DOI PubMed
156. Wan Y, Liu B, Lei H, et al. Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation
detection in early-stage non-small-cell lung cancer. Ann Oncol 2018;29:2379-83. DOI PubMed PMC
157. Castillo J, Bernard V, San Lucas FA, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid
biopsies from pancreatic cancer patients. Ann Oncol 2018;29:223-9. DOI PubMed PMC
158. Lázaro-Ibáñez E, Sanz-Garcia A, Visakorpi T, et al. Different gDNA content in the subpopulations of prostate cancer extracellular
vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate 2014;74:1379-90. DOI PubMed PMC
159. Krug AK, Enderle D, Karlovich C, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor
DNA in NSCLC patient plasma. Ann Oncol 2018;29:700-6. DOI PubMed PMC
160. Bernard V, Kim DU, San Lucas FA, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer.
Gastroenterology 2019;156:108-18.e4. DOI PubMed PMC
161. Castellanos-Rizaldos E, Grimm DG, Tadigotla V, et al. Exosome-based detection of EGFR T790M in plasma from non-small cell
lung cancer patients. Clin Cancer Res 2018;24:2944-50. DOI PubMed
162. Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat
Rev Cancer 2017;17:223-38. DOI
163. Cheng L, Hill AF. Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discov 2022;21:379-99. DOI PubMed
164. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-
derived exosomes. Nat Med 1998;4:594-600. DOI PubMed
165. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of
targeted exosomes. Nat Biotechnol 2011;29:341-5. DOI
166. Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Nature 2017;546:498-503. DOI PubMed PMC
167. Mendt M, Kamerkar S, Sugimoto H, et al. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight

